Literature DB >> 18591290

Public healthcare resource allocation and the Rule of Rescue.

R Cookson1, C McCabe, A Tsuchiya.   

Abstract

In healthcare, a tension sometimes arises between the injunction to do as much good as possible with scarce resources and the injunction to rescue identifiable individuals in immediate peril, regardless of cost (the "Rule of Rescue"). This tension can generate serious ethical and political difficulties for public policy makers faced with making explicit decisions about the public funding of controversial health technologies, such as costly new cancer drugs. In this paper we explore the appropriate role of the Rule of Rescue in public resource allocation decisions by health technology funding advisory bodies such as the National Institute for Health and Clinical Excellence. We consider practical approaches to operationalising the Rule of Rescue from Australia and the UK before examining the relevance of individual moral imperatives to public policy making. We conclude that that whilst public policy makers in a humane society should facilitate exceptional departures from a cost effectiveness norm in clinical decisions about identified individuals, it is not so obvious that they should, as a matter of national public policy, exempt any one group of unidentified individuals within society from the rules of opportunity cost at the expense of all others.

Entities:  

Mesh:

Year:  2008        PMID: 18591290     DOI: 10.1136/jme.2007.021790

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  21 in total

1.  Toward a more universal approach in health valuation.

Authors:  Benjamin M Craig; Jan J V Busschbach
Journal:  Health Econ       Date:  2011-07       Impact factor: 3.046

2.  Orphan drugs for rare diseases: is it time to revisit their special market access status?

Authors:  Steven Simoens; David Cassiman; Marc Dooms; Eline Picavet
Journal:  Drugs       Date:  2012-07-30       Impact factor: 9.546

Review 3.  Societal values in the allocation of healthcare resources: is it all about the health gain?

Authors:  Tania Stafinski; Devidas Menon; Deborah Marshall; Timothy Caulfield
Journal:  Patient       Date:  2011       Impact factor: 3.883

4.  Access to health care for illegal migrants: ethical implications of a new health policy in the UK.

Authors:  Roghieh Dehghan Zaklaki
Journal:  Br J Gen Pract       Date:  2019-02       Impact factor: 5.386

5.  Effects of Changes in ICU Bed Supply on ICU Utilization.

Authors:  Ian J Barbash; David J Wallace; Jeremy M Kahn
Journal:  Med Care       Date:  2019-07       Impact factor: 2.983

6.  Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab.

Authors:  Thomas E Delea; Paul Tappenden; Oleg Sofrygin; Dominy Browning; Mayur M Amonkar; Jon Karnon; Mel D Walker; David Cameron
Journal:  Eur J Health Econ       Date:  2011-06-24

Review 7.  Ethical issues with newborn screening in the genomics era.

Authors:  Beth A Tarini; Aaron J Goldenberg
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-05-01       Impact factor: 8.929

8.  Action Guide for Addressing Ethical Challenges of Resource Allocation Within Community-Based Healthcare Organizations.

Authors:  Krista L Harrison; Holly A Taylor; Maria W Merritt
Journal:  J Clin Ethics       Date:  2018

Review 9.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

10.  Knowledge of medical ethics among Nigerian medical doctors.

Authors:  Joseph O Fadare; Olufemi O Desalu; Abiodun C Jemilohun; Oluwole A Babatunde
Journal:  Niger Med J       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.